361
Views
9
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases

, , , , , , , , , ORCID Icon, , , , , , , , , ORCID Icon & ORCID Icon show all
Pages 471-476 | Received 03 Jan 2018, Accepted 08 May 2018, Published online: 22 Jul 2018

References

  • Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21–33.
  • Kumar SK, Dispenzieri A, Lacy MQ, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122–1128.
  • Blade J, Kyle RA. Multiple myeloma in young patients: clinical presentation and treatment approach. Leuk Lymphoma. 1998;30:493–501.
  • Waxman AJ, Mink PJ, Devesa SS, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010;116:5501–5506.
  • Hewell GM, Alexanian R. Multiple myeloma in young persons. Ann Intern Med. 1976;84:441–443.
  • Lazarus HM, Kellermeyer RW, Aikawa M, et al. Multiple myeloma in young men. Clinical course and electron microscopic studies of bone marrow plasma cells. Cancer. 1980;46:1397–1400.
  • Blade J, Kyle RA, Greipp PR. Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Haematol. 1996;93:345–351.
  • Blade J, Kyle RA, Greipp PR. Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature. Arch Intern Med. 1996;156:1463–1468.
  • Cheema PK, Zadeh S, Kukreti V, et al. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transplant. Biol Blood Marrow Transplant. 2009;15:686–693.
  • Corso A, Klersy C, Lazzarino M, et al. Multiple myeloma in younger patients: the role of age as prognostic factor. Ann Hematol. 1998;76:67–72.
  • Ludwig H, Durie BG, Bolejack V, et al. Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group. Blood 2008;111:4039–4047.
  • Ludwig H, Bolejack V, Crowley J, et al. Survival and years of life lost in different age cohorts of patients with multiple myeloma. J Clin Oncol. 2010;28:1599–1605.
  • Jurczyszyn A, Nahi H, Avivi I, et al. Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study. Br J Haematol. 2016;175:884–891.
  • Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467–1473.
  • Surveillance, Epidemiology and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence ? SEER 9 Regs Research Data, Nov 2016 Sub (1973–2014) <Katrina/Rita Population Adjustment> - Linked to County Attributes ? Total U.S., 1969–2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Released April 2017, Based On the November 2016 Submission.
  • Nilsson T, Lenhoff S, Turesson I, et al. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation. Eur J Haematol. 2002;68:345–353.
  • Sagaster V, Kaufmann H, Odelga V, et al. Chromosomal abnormalities of young multiple myeloma patients (<45 years) are not different from those of other age groups and are independent of stage according to the International Staging System. Eur J Haematol. 2007;78:227–234.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.